MedTrace Logo

Bacteriophage Therapy in Patients With Prosthetic Joint Infections

NCT04787250 · Status: WITHDRAWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL

Last updated 2022-04-04

No results posted yet for this study

Summary

This is a study designed to evaluate bacteriophage therapy in patients with chronic prosthetic joint infections.

Conditions

  • Prosthetic Joint Infection

Interventions

BIOLOGICAL

Phage Therapy

Phage will be administered based on patient's matching results.

PROCEDURE

Two-Stage Exchange Arthroplasty

Performed per the study center's standard of care. No investigational products are used.

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER

  • Adaptive Phage Therapeutics, Inc.

    lead INDUSTRY

Principal Investigators

  • Robert J Hopkins, MD · Adaptive Phage Therapeutics

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2023-05-31
Completion
2024-05-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04787250 on ClinicalTrials.gov